Global End-Stage Renal Disease Market

Global End-Stage Renal Disease (ESRD) Market Size, Share, Growth Analysis, By Treatment(Dialysis, Kidney and Transplantation), By End-user(hospitals and clinics, and home care settings) - Industry Forecast 2024-2031


Report ID: SQMIG35J2054 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 61 | Figures: 75

Global End-Stage Renal Disease (ESRD) Market Insights

Global End-Stage Renal Disease Market size was valued at USD 99.2 Billion in 2022 and is poised to grow from USD 112.2 Billion in 2023 to USD 300.38 Billion by 2031, at a CAGR of 13.10% during the forecast period (2024-2031).

The increasing number of individuals suffering from kidney failure and the introduction of advanced medical devices, such as low-maintenance dialysis equipment and artificial kidneys, are key drivers of this market. Chronic Kidney Disease (CKD) is a major cause of kidney failure, often resulting from conditions that lead to reduced kidney function. CKD can gradually develop over time and eventually progress to ESRD, also known as kidney failure. Factors such as hypertension, diabetes, smoking, and the aging population contribute to the development of ESRD, with diabetes being the most common cause and hypertension being the second-most frequent cause. Treatment options for ESRD/CKD include kidney transplantation or dialysis to sustain life. CKD has a high incidence rate globally, with approximately 10% of the global population suffering from the condition, leading to millions of deaths each year. The geriatric population in developing countries, such as China and India, is particularly affected. The number of patients requiring kidney transplants or dialysis is increasing at a rate of 5-7% annually. The prevalence of CKD is higher in women than men, and the rising number of individuals with hypertension and diabetes further contributes to the growth of the market. Diabetes is the primary cause of advanced kidney disease, followed by hypertension, affecting approximately 1 billion individuals worldwide. Baxter, a prominent company in this market, has announced strategic initiatives to enhance operational effectiveness and innovation, including spinning out their renal care and acute treatments global business units into a separate organization.

Regions like Africa, China, the Rest of Asia Pacific, the U.S., Taiwan, Japan, Germany, France, and Belgium have observed a high prevalence of ESRD in recent years. In the U.S., around 80 million people, or 1 in 3 adults, are at risk of CKD, making it the ninth leading cause of death. Developing countries like China and India are projected to witness an increase in cases of renal failure, particularly among the elderly population. The market growth is further supported by technological advancements in the treatment of renal failure. For example, the approval of human clinical trials for the Wearable Artificial Kidney 2.0 by the U.S. FDA in 2014 showcases the development of innovative blood purification technologies for kidney failure patients. The presence of numerous hospitals and a well-developed healthcare infrastructure in the U.S. also contributes to market growth. With a significant number of hospital admissions for acute kidney injury (AKI), there is a growing demand for dialysis and transplantation. Additionally, the number of dialysis clinics and treatment centers is increasing, with approximately 7,500 dialysis clinics currently operating in the U.S.

US End-Stage Renal Disease (ESRD) Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 99.2 Billion

Largest Segment

Dialysis

Fastest Growth

Dialysis

Growth Rate

13.10% CAGR

Global End-Stage Renal Disease (ESRD) Market ($ Bn)
Country Share for North America Region (%)
Global End-Stage Renal Disease (ESRD) Market By Treatment ($ Bn)
Global End-Stage Renal Disease (ESRD) Market By Treatment (%)

To get more reports on the above market click here to Buy The Report

Global End-Stage Renal Disease (ESRD) Market Segmental Analysis

The Global End-Stage Renal Disease Market is segmented by treatment, end-user, technique and region. Based on Treatment, the market can be segmented into dialysis, kidney and transplantation. Based on end-user, the market is segmented into hospitals and clinics, and home care settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

End-Stage Renal Disease Market Analysis by Treatment

By treatment, the market can be segmented into dialysis, kidney and transplantation. Dialysis represents the dominating segment in the ESRD market. Dialysis is the primary treatment method for patients with end-stage renal disease. It can be further divided into hemodialysis and peritoneal dialysis. Hemodialysis involves filtering waste products and excess fluids from the blood using a dialyzer machine, while peritoneal dialysis utilizes the peritoneum as a natural filter.

Kidney transplantation represents the fastest-growing segment in the ESRD market. It involves surgically replacing a diseased kidney with a healthy kidney from a living or deceased donor. This treatment option offers several advantages over long-term dialysis, such as improved quality of life, reduced treatment burden, and better long-term outcomes.

End-Stage Renal Disease Market Analysis by End-user

By end-user, the market can be segmented into hospitals and clinics, and home care settings. Hospitals and Clinics play a crucial role in the treatment and management of ESRD. They serve as primary care settings where patients receive comprehensive medical services, including dialysis treatments and kidney transplantation procedures. Hospitals and Clinics are equipped with specialized dialysis units, operation theaters, and intensive care facilities, allowing for comprehensive care of ESRD patients.

Home Care Settings represent the fastest growing segment in the ESRD market. It involves providing ESRD treatments and services, such as dialysis, in the comfort and convenience of patients' homes. Home dialysis allows patients to receive treatment in the familiar environment of their own homes, providing greater comfort and convenience. It enables them to have more control over their treatment schedule and reduces the need for frequent hospital visits.

Global End-Stage Renal Disease (ESRD) Market By Treatment, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Global End-Stage Renal Disease (ESRD) Market Regional Insights

The United States is a dominating region in the global end-stage renal disease (ESRD) market. It has a well-developed healthcare infrastructure and a significant number of hospitals, including community hospitals and federal government hospitals. The United States also has a large number of dialysis clinics, approximately 7,500 currently, catering to the increasing prevalence of ESRD. The country witnesses a high incidence of CKD and ESRD, with around 80 million people, or 1 in 3 American adults, at risk of CKD. This makes CKD the ninth leading cause of death in the United States. The presence of advanced medical technologies, research and development activities, and favorable reimbursement policies contribute to the dominance of the United States in the ESRD market.

Asia Pacific is the fastest growing region in the global end-stage renal disease market. Developing countries in this region, such as China and India, have witnessed a significant increase in the prevalence of ESRD. The geriatric population in these countries is particularly affected, leading to a rising number of patients requiring kidney transplants or dialysis. The increasing incidence of hypertension and diabetes, along with lifestyle changes, contribute to the growing burden of CKD in the Asia Pacific region. Additionally, advancements in healthcare infrastructure, technological innovations, and increasing awareness about kidney diseases and treatment options are driving the market growth in this region. The presence of a large population base and improving healthcare facilities create opportunities for market expansion and investment in the Asia Pacific region.

Global End-Stage Renal Disease (ESRD) Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global End-Stage Renal Disease (ESRD) Market Dynamics

End-Stage Renal Disease Market Drivers

Increasing prevalence of chronic kidney disease (CKD)

  • One significant driver in the global end-stage renal disease market is the increasing prevalence of chronic kidney disease (CKD), particularly driven by conditions such as hypertension and diabetes. With a high number of individuals worldwide being affected by these chronic diseases, the risk of developing CKD and eventually progressing to ESRD rises. This escalating patient population necessitates the demand for effective treatment options, including kidney transplantation or dialysis, thereby propelling the growth of the market.

End-Stage Renal Disease Market Restraints

Limited availability and accessibility of treatment options

  • One notable restraint in the global end-stage renal disease market is the limited availability and accessibility of treatment options, such as kidney transplantation. The demand for kidney transplants far exceeds the supply of suitable organs, leading to long waiting lists and delays in receiving a transplant. Additionally, dialysis, while an effective treatment, poses challenges in terms of patient compliance, cost, and the need for regular sessions. These limitations create barriers to timely and optimal treatment for individuals with end-stage renal disease, impacting market growth.

Request Free Customization of this report to help us to meet your business objectives.

Global End-Stage Renal Disease (ESRD) Market Competitive Landscape

The global end-stage renal disease (ESRD) market is characterized by the presence of several companies striving to develop innovative treatment solutions. These companies focus on research and development activities to introduce technologically advanced products in the market. Additionally, strategic initiatives such as partnerships, collaborations, and acquisitions are commonly observed in the industry. The competitive environment is driven by the pursuit of enhancing operational effectiveness, accelerating innovation, and improving patient outcomes. Market players aim to gain a competitive edge by offering comprehensive solutions and expanding their geographical presence.

End-Stage Renal Disease Market Top Player’s Company Profiles

  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Baxter International Inc. (US)
  • Davita Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Nikkiso Co., Ltd. (Japan)
  • NxStage Medical, Inc. (US)
  • Asahi Kasei Corporation (Japan)
  • Rockwell Medical, Inc. (US)
  • Cantel Medical Corporation (US)
  • Medtronic plc (Ireland)
  • Terumo Corporation (Japan)
  • Nipro Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Stryker Corporation (US)
  • Allmed Medical Corporation (China)
  • Fresenius Kabi AG (Germany)
  • Dialysis Clinic, Inc. (US)
  • Toray Medical Co., Ltd. (Japan)
  • Medivators Inc. (US)
  • Quanta Dialysis Technologies Ltd. (UK)

End-Stage Renal Disease Market Recent Developments

  • In June 2023, Outset Medical partnered with American Renal Associates Holdings to expand the adoption of the Tablo Hemodialysis System across American Renal's dialysis centers.
  • In May 2023, DaVita Inc. acquired Atlas Renal Ventures, adding eight dialysis centers in Florida to its network.
  • In April 2023, Quanta Dialysis Technologies secured $245 million in a funding round led by BlackRock, supporting the global commercialization of its SC+ portable hemodialysis system.
  • In March 2023, Medtronic, a global medical technology company, acquired Coridea, a developer of cardiovascular devices, to enhance its portfolio of solutions for patients with kidney disease.
  • In February 2023, Cricket Health, a kidney care company, raised $83.5 million in a funding round to expand its specialized care and support services for individuals with kidney disease.

Global End-Stage Renal Disease (ESRD) Key Market Trends

  • One key market trend in the global end-stage renal disease (ESRD) market is the increasing adoption of home-based dialysis treatments. This trend is driven by the desire to improve patient convenience, reduce healthcare costs, and enhance patient outcomes. Home dialysis therapies, such as peritoneal dialysis and home hemodialysis, offer greater flexibility, independence, and the ability to receive treatment in the comfort of one's own home. This shift towards home-based dialysis is being supported by advancements in technology, improved training programs, and favorable reimbursement policies, thus driving the growth of the market.

Global End-Stage Renal Disease (ESRD) Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global end-stage renal disease (ESRD) market analysis, the market is witnessing significant growth due to the increasing number of patients suffering from kidney failure and the introduction of advanced medical technologies. Chronic kidney disease (CKD), often caused by conditions like hypertension and diabetes, leads to ESRD, driving the demand for kidney transplants and dialysis treatments. The United States dominates the market with its well-developed healthcare infrastructure and numerous hospitals and dialysis clinics. Asia Pacific emerges as the fastest growing region, fueled by the rising prevalence of ESRD in countries like China and India. The market is also influenced by trends like the adoption of home-based dialysis treatments and technological advancements.

Report Metric Details
Market size value in 2023 USD 99.2 Billion
Market size value in 2031 USD 300.38 Billion
Growth Rate 13.10%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Treatment
    • Dialysis, Kidney and Transplantation
  • End-user
    • hospitals and clinics, and home care settings
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Baxter International Inc. (US)
  • Davita Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Nikkiso Co., Ltd. (Japan)
  • NxStage Medical, Inc. (US)
  • Asahi Kasei Corporation (Japan)
  • Rockwell Medical, Inc. (US)
  • Cantel Medical Corporation (US)
  • Medtronic plc (Ireland)
  • Terumo Corporation (Japan)
  • Nipro Corporation (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • Stryker Corporation (US)
  • Allmed Medical Corporation (China)
  • Fresenius Kabi AG (Germany)
  • Dialysis Clinic, Inc. (US)
  • Toray Medical Co., Ltd. (Japan)
  • Medivators Inc. (US)
  • Quanta Dialysis Technologies Ltd. (UK)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global End-Stage Renal Disease (ESRD) Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global End-Stage Renal Disease (ESRD) Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global End-Stage Renal Disease (ESRD) Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global End-Stage Renal Disease (ESRD) Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global End-Stage Renal Disease (ESRD) Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global End-Stage Renal Disease (ESRD) Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global End-Stage Renal Disease Market size was valued at USD 99.2 Billion in 2022 and is poised to grow from USD 112.2 Billion in 2023 to USD 300.38 Billion by 2031, at a CAGR of 13.10% during the forecast period (2024-2031).

The global end-stage renal disease (ESRD) market is characterized by the presence of several companies striving to develop innovative treatment solutions. These companies focus on research and development activities to introduce technologically advanced products in the market. Additionally, strategic initiatives such as partnerships, collaborations, and acquisitions are commonly observed in the industry. The competitive environment is driven by the pursuit of enhancing operational effectiveness, accelerating innovation, and improving patient outcomes. Market players aim to gain a competitive edge by offering comprehensive solutions and expanding their geographical presence. 'Fresenius Medical Care AG & Co. KGaA (Germany)', 'Baxter International Inc. (US)', 'Davita Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Nikkiso Co., Ltd. (Japan)', 'NxStage Medical, Inc. (US)', 'Asahi Kasei Corporation (Japan)', 'Rockwell Medical, Inc. (US)', 'Cantel Medical Corporation (US)', 'Medtronic plc (Ireland)', 'Terumo Corporation (Japan)', 'Nipro Corporation (Japan)', 'Kawasumi Laboratories, Inc. (Japan)', 'Stryker Corporation (US)', 'Allmed Medical Corporation (China)', 'Fresenius Kabi AG (Germany)', 'Dialysis Clinic, Inc. (US)', 'Toray Medical Co., Ltd. (Japan)', 'Medivators Inc. (US)', 'Quanta Dialysis Technologies Ltd. (UK)'

One significant driver in the global end-stage renal disease market is the increasing prevalence of chronic kidney disease (CKD), particularly driven by conditions such as hypertension and diabetes. With a high number of individuals worldwide being affected by these chronic diseases, the risk of developing CKD and eventually progressing to ESRD rises. This escalating patient population necessitates the demand for effective treatment options, including kidney transplantation or dialysis, thereby propelling the growth of the market.

One key market trend in the global end-stage renal disease (ESRD) market is the increasing adoption of home-based dialysis treatments. This trend is driven by the desire to improve patient convenience, reduce healthcare costs, and enhance patient outcomes. Home dialysis therapies, such as peritoneal dialysis and home hemodialysis, offer greater flexibility, independence, and the ability to receive treatment in the comfort of one's own home. This shift towards home-based dialysis is being supported by advancements in technology, improved training programs, and favorable reimbursement policies, thus driving the growth of the market.

The United States is a dominating region in the global end-stage renal disease (ESRD) market. It has a well-developed healthcare infrastructure and a significant number of hospitals, including community hospitals and federal government hospitals. The United States also has a large number of dialysis clinics, approximately 7,500 currently, catering to the increasing prevalence of ESRD. The country witnesses a high incidence of CKD and ESRD, with around 80 million people, or 1 in 3 American adults, at risk of CKD. This makes CKD the ninth leading cause of death in the United States. The presence of advanced medical technologies, research and development activities, and favorable reimbursement policies contribute to the dominance of the United States in the ESRD market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global End-Stage Renal Disease Market

Product ID: SQMIG35J2054

$5,300
BUY NOW GET FREE SAMPLE